Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Bitting, Rhonda Lynn
Healy, Patrick
Halabi, Susan
George, Daniel J.
Ko, Jung Hyun
Armstrong, Andrew J.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Duke Univ Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5031
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluation of a composite biomarker panel including circulating tumor cell (CTC) enumeration as a surrogate for survival in metastatic castration-resistant prostate cancer (mCRPC)
    Scher, H. I.
    Heller, G.
    Molina, A.
    Attard, G.
    McCormack, R.
    Riisnaes, R.
    Kheoh, T.
    Fleisher, M.
    Buyse, M.
    De Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S679 - S679
  • [2] Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    George, Daniel J.
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY.
    Tagawa, Scott T.
    Galletti, Giuseppe
    Antonarakis, Emmanuel S.
    Tasaki, Shinsuke
    Gjyrezi, Ada
    Worroll, Daniel
    Portella, Luigi
    Kirby, Brian J.
    Stewart, John
    Zaher, Atef
    Saad, Fred
    Vanhuyse, Marie
    Suri, Shalu
    Lannin, Timothy B.
    Gruber, Conor
    Pratt, Erica
    Sonpavde, Guru
    Eisenberger, Mario A.
    Nanus, David M.
    Giannakakou, Paraskevi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC)
    Kaur, Gurveen
    Singh, Beerinder
    Beltran, Himisha
    Akhtar, Naveed Hassan
    Nanus, David M.
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer
    Bitting, Rhonda L.
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Goodin, Michael
    Armstrong, Andrew J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 110.e1 - 110.e9
  • [6] Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study).
    Fleisher, Martin
    Danila, Daniel Costin
    Fizazi, Karim
    Hirmand, Mohammad
    Selby, Brian
    Phung, De
    De Bono, Johann Sebastian
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.
    Lorente, David
    Olmos, David
    Mateo, Joaquin
    Zafeiriou, Zafeiris
    Rescigno, Pasquale
    Bianchini, Diletta
    Mehra, Niven
    Molina, Arturo
    Kheoh, Thian
    Baeten, Kurt
    Mccormack, Robert Thomas
    Terstappen, Leon W. M. M.
    Scher, Howard I.
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Impact of circulating tumor cell (CTC) nucleus size on outcomes with abiraterone acetate (AA) therapy in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gill, David Michael
    Agarwal, Neeraj
    Hahn, Andrew W.
    Johnson, Eric
    Poole, Austin
    Carroll, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY
    Tagawa, S. T.
    Galletti, G.
    Antonarakis, E. S.
    Tasaki, S.
    Gjyrezi, A.
    Worroll, D.
    Portella, L.
    Kirby, B. J.
    Stewart, J.
    Zaher, A.
    Saad, F.
    Vanhuyse, M.
    Suri, S.
    Lannin, T. B.
    Gruber, C.
    Pratt, E.
    North, S.
    Eisenberger, M. A.
    Nanus, D. M.
    Giannakakou, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S498 - S499
  • [10] Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).
    Keegan, Niamh M.
    Arfe, Andrea
    Barnett, Ethan
    Cohn, Erica Dayan
    Zhao, Jimmy
    Carbone, Emily
    Zanone, Michelle
    Anderson, Amanda
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345